These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36658130)

  • 1. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells.
    Seo MJ; Kim IY; Lee DM; Park YJ; Cho MY; Jin HJ; Choi KS
    Cell Death Dis; 2023 Jan; 14(1):42. PubMed ID: 36658130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca
    Lee HJ; Lee DM; Seo MJ; Kang HC; Kwon SK; Choi KS
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
    Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
    Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
    Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
    Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress.
    Lee DM; Seo MJ; Lee HJ; Jin HJ; Choi KS
    Biochem Biophys Res Commun; 2022 Mar; 596():56-62. PubMed ID: 35114585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
    Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells.
    Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y
    Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1).
    Zhao L; Zhong B; Zhu Y; Zheng H; Wang X; Hou Y; Lu JJ; Ai N; Guo X; Ge W; Ma YY; Chen X
    Biochem Pharmacol; 2023 Apr; 210():115487. PubMed ID: 36893814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA.
    Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G
    Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Cell Cycle; 2016; 15(4):559-72. PubMed ID: 26743692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
    Johnson SS; Liu D; Ewald JT; Robles-Planells C; Pulliam C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Menda Y; Spitz DR; Fath MA
    Cancer Biol Ther; 2024 Dec; 25(1):2382524. PubMed ID: 39054566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 8-hydroxyquinoline derivative induces breast cancer cell death through paraptosis and apoptosis.
    Ma L; Xuan X; Fan M; Zhang Y; Yuan G; Huang G; Liu Z
    Apoptosis; 2022 Aug; 27(7-8):577-589. PubMed ID: 35674852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
    Habermann KJ; Grünewald L; van Wijk S; Fulda S
    Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death.
    Szeliga M; Rola R
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2016 Jan; 35(1):546-51. PubMed ID: 26530353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auranofin and Cold Atmospheric Plasma Synergize to Trigger Distinct Cell Death Mechanisms and Immunogenic Responses in Glioblastoma.
    Van Loenhout J; Freire Boullosa L; Quatannens D; De Waele J; Merlin C; Lambrechts H; Lau HW; Hermans C; Lin A; Lardon F; Peeters M; Bogaerts A; Smits E; Deben C
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.
    Liu C; Liu Z; Li M; Li X; Wong YS; Ngai SM; Zheng W; Zhang Y; Chen T
    PLoS One; 2013; 8(1):e53945. PubMed ID: 23342042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Ca
    Kim E; Lee DM; Seo MJ; Lee HJ; Choi KS
    Front Cell Dev Biol; 2020; 8():607844. PubMed ID: 33585447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.
    Lee DM; Kim IY; Seo MJ; Kwon MR; Choi KS
    Exp Mol Med; 2017 Aug; 49(8):e365. PubMed ID: 28798402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.